These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. COX-2: a molecular target for colorectal cancer prevention. Brown JR, DuBois RN. J Clin Oncol; 2005 Apr 20; 23(12):2840-55. PubMed ID: 15837998 [Abstract] [Full Text] [Related]
3. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor. Lal G, Ash C, Hay K, Redston M, Kwong E, Hancock B, Mak T, Kargman S, Evans JF, Gallinger S. Cancer Res; 2001 Aug 15; 61(16):6131-6. PubMed ID: 11507063 [Abstract] [Full Text] [Related]
4. Role of cyclooxygenase-2 in the angiogenesis of colorectal cancer. Rao M, Yang W, Seifalian AM, Winslet MC. Int J Colorectal Dis; 2004 Jan 15; 19(1):1-11. PubMed ID: 12783255 [Abstract] [Full Text] [Related]
5. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma]. Tuynman JB, Hulscher JB, Steller EP, van Lanschot JJ, Richel DJ. Ned Tijdschr Geneeskd; 2003 Nov 08; 147(45):2207-12. PubMed ID: 14640057 [Abstract] [Full Text] [Related]
8. Role of cyclooxygenase inhibitors for the prevention of colorectal cancer. Stack E, DuBois RN. Gastroenterol Clin North Am; 2001 Dec 08; 30(4):1001-10. PubMed ID: 11764529 [Abstract] [Full Text] [Related]
9. COX-2 inhibition in clinical cancer prevention. Lynch PM. Oncology (Williston Park); 2001 Mar 08; 15(3 Suppl 5):21-6. PubMed ID: 11301836 [Abstract] [Full Text] [Related]
11. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate. Crew TE, Elder DJ, Paraskeva C. Carcinogenesis; 2000 Jan 08; 21(1):69-77. PubMed ID: 10607736 [Abstract] [Full Text] [Related]
13. Use of NSAIDs for the chemoprevention of colorectal cancer. Herendeen JM, Lindley C. Ann Pharmacother; 2003 Nov 08; 37(11):1664-74. PubMed ID: 14565811 [Abstract] [Full Text] [Related]
14. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Gupta RA, Dubois RN. Nat Rev Cancer; 2001 Oct 08; 1(1):11-21. PubMed ID: 11900248 [Abstract] [Full Text] [Related]
15. Cyclooxygenase-2: a target for the prevention and treatment of breast cancer. Howe LR, Subbaramaiah K, Brown AM, Dannenberg AJ. Endocr Relat Cancer; 2001 Jun 08; 8(2):97-114. PubMed ID: 11397667 [Abstract] [Full Text] [Related]
17. Cyclooxygenase as a target for colorectal cancer chemoprevention. Moreira L, Castells A. Curr Drug Targets; 2011 Dec 08; 12(13):1888-94. PubMed ID: 21158711 [Abstract] [Full Text] [Related]
18. Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas. Fujita T, Matsui M, Takaku K, Uetake H, Ichikawa W, Taketo MM, Sugihara K. Cancer Res; 1998 Nov 01; 58(21):4823-6. PubMed ID: 9809985 [Abstract] [Full Text] [Related]
19. Cyclooxygenase-2 and gastrointestinal cancer. Mann JR, DuBois RN. Cancer J; 2004 Nov 01; 10(3):145-52. PubMed ID: 15285921 [Abstract] [Full Text] [Related]